National University of Singapore researcher Dean Ho discusses the role of artificial intelligence in cancer care in Science this week. In a perspective piece, Ho describes how AI can accelerate drug discovery, for instance by leveraging genomic and chemical data in lieu of large-scale screening studies, as well as drug development by analyzing biomarker and electronic health record data to match patients to clinical trials.